We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 23 MAY 2012
GSK And Genentech Settle Cabilly Patent Lawsuit
Beeser Ramamoorthy LLP
GlaxoSmithKline and Genentech have settled a U.S. lawsuit related to Genentech's Cabilly II (US 6,331,415) and Cabilly III (US 7,923,221) patents.
United StatesIntellectual Property










